14 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

AccelFix Spinal Fixation System

FDA 510(k)
FDA Class 2 ·Orthopedic

N/A

FDA UDI
STRYKER SUSTAINABILITY SOLUTIONS, INC.·00885825003739·Steerable Diagnostic EP Catheter , LARGE 4.0, 8...

N/A

FDA UDI
STRYKER SUSTAINABILITY SOLUTIONS, INC.·00885825003746·Steerable Diagnostic EP Catheter , LARGE 4.0, 8...

MODIFICATION TO MARSPO2, MODEL 2001

FDA 510(k)
FDA Class 2 ·Cardiovascular

SALICYLATE ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

UNK

FDA Adverse Event
Injury ·NEUROMODULATION·Product code EZW·November 5, 2007

PARADIGM REAL-TIME INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code OYC·October 24, 2014

PARADIGM REAL-TIME INSULIN INFUSION PUMP

FDA Adverse Event
Injury ·MEDTRONIC PUERTO RICO OPERATIONS MED-REL·Product code MDS·July 29, 2011

COULTER® LH 750 HEMATOLOGY ANALYXZER

FDA Adverse Event
Malfunction ·BECKMAN COULTER·Product code GKZ·July 2, 2013

BARD EP XT Steerable, Product Number 200794; REPROCESSED ELECTROPHYSIOLOGY CATHETER

FDA Recall
Open, Classified ·Stryker Sustainability Solutions·Product code NLH·April 10, 2026

BARD EP XT Steerable, Product Number 200794; REPROCESSED ELECTROPHYSIOLOGY CATHETER

FDA Enforcement
Class II ·Ongoing·Stryker Sustainability Solutions·May 20, 2026

Stryker End Cap, Standard T2 Humerus ¿6 mm Catalog Number: 18300003S - Product Usage: Stryker implants are single use devices intended for the temporary fixation, correction or stabilization of bones.

FDA Enforcement
Class II ·Terminated·Stryker GmbH·June 24, 2020

PROXIMATE*HCS HEMORR CIR STAPL

FDA Adverse Event
Injury ·ETHICON ENDO-SURGERY, LLC.·Product code GDW·July 26, 2019

EMBLEM MRI S-ICD pulse generators, as part of Boston Scientific S-ICD System; Model A219

FDA Enforcement
Class II ·Ongoing·Boston Scientific Corporation·February 3, 2021